- Location
1
result for "
Alkylating Agents
"-
Mundipharma and Northlake International Have Joined Forces to Develop New Agents
Dec 4, 2012Mundipharma and Northlake International have joined forces to develop structurally new next generation alkylating agents to treat haematological malignancies. Under the $84.5m agreement, Mundipharma and its independent associated ...
Tags: Alkylating Agents, haematological malignancies, alkylation efficiency
Related Products
-
Hydroxyl Protecting Agent Tert-Butyldimethylsilyl Chloride for Silicon Alkylating Agent CAS 18162-48-6
-
Factory Direct Supply Price N-Butyllithium with Fast Delivery CAS 109-72-8
-
High Quality Tert-Butyl Bromoacetate CAS 5292-43-3
-
Hydroxyl Protecting Agent Tert-Butyldimethylsilyl Chloride for Silicon Alkylating Agent CAS 18162-48-6
